Drug recall · January 30, 2019
Ezetimibe and Simvastatin Tablets 10mg/80 mg recall
Why: Presence of Foreign Substance: Product complaint of black speckles observed on tablets.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ezetimibe and Simvastatin Tablets 10mg/80 mg, 1000-count bottles, Rx only, Manufactured by: Teva Pharmaceuticals Ind. Ltd. Jerusalem, 9777402, Israel; Distributed by: Dr. Reddy's Laboratories Inc. Princeton, NJ 08540 USA, NDC 43598-586-10
- Lots / codes
Lot #: 43E021 and 43E023, Exp. 01/2020
- Quantity
- 118 bottles
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- Nationwide within the United States
- Initiated
- January 15, 2019 · Voluntary: Firm initiated
- Classified
- January 22, 2019
- Reported
- January 30, 2019
- Ended
- March 3, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Simvastatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.